We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Transcept Strikes Home on Third Try for Insomnia Drug Intermezzo
Transcept Strikes Home on Third Try for Insomnia Drug Intermezzo
December 2, 2011
The FDA has approved Transcept Pharmaceuticals’ insomnia drug Intermezzo on its third NDA attempt that followed two complete response letters.